Ideaya Biosciences: These Prices Are Probably Going To Look Cheap Sooner Than Later

Core Insights - IDEAYA Biosciences (NASDAQ: IDYA) is a developmental biotech company that has generated interesting data but may be overvalued based on previous assessments [1] Company Analysis - The company is involved in the biotech sector, focusing on clinical trials and innovative data generation [1] - The analyst has a background in biochemistry and extensive experience in analyzing biotech companies, indicating a strong foundation for evaluating IDEAYA's potential [1] Market Position - IDEAYA's valuation has been questioned, suggesting that while the company has promising data, its market price may not reflect its actual value [1]